User profiles for K. Kahler

Kristijan H Kahler

Novartis Pharmaceuticals
Verified email at novartis.com
Cited by 4566

Methods for evaluation of medication adherence and persistence using automated databases

SE Andrade, KH Kahler, F Frech… - … and drug safety, 2006 - Wiley Online Library
Purpose Our aim was to perform a systematic review of the methods currently being used to
assess adherence and persistence in pharmacoepidemiological and pharmacoeconomic …

[HTML][HTML] Human gut microbiota: toward an ecology of disease

…, MA Johnston, MR Kahler, K Kaler… - Frontiers in …, 2017 - frontiersin.org
Composed of trillions of individual microbes, the human gut microbiota has adapted to the
uniquely diverse environments found in the human intestine. Quickly responding to the …

The surface chemistry of ZnO nanoparticles applied as heterogeneous catalysts in methanol synthesis

J Strunk, K Kähler, X Xia, M Muhler - Surface science, 2009 - Elsevier
Zinc oxide has a variety of applications in catalysis both as support and as active phase for
hydrogenation or dehydrogenation reactions. This review provides an overview of the surface …

Controlled outgrowth of dissociated neurons on patterned substrates

D Kleinfeld, KH Kahler… - Journal of Neuroscience, 1988 - Soc Neuroscience
The cytoarchitecture of nervous tissue is lost during the dissociation procedures used to form
primary cell cultures. As a first step toward reestablishing an ordered arrangement of these …

Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective …

…, GH Tomberlin, AM Hassell, KM Kahler… - Journal of medicinal …, 2012 - ACS Publications
Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is activated in response
to a variety of endoplasmic reticulum stresses implicated in numerous disease states. …

[HTML][HTML] The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

…, SM Goldinger, C Loquai, C Robert, KC Kaehler… - PloS one, 2013 - journals.plos.org
Background Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody,
has been approved for the treatment of metastatic melanoma and induces adverse events (AE) …

STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies

…, P Arlett, Y Uyama, JA Berlin, DB Bartels, KH Kahler… - Bmj, 2021 - bmj.com
In alignment with the International Council of Harmonization’s strategic goals, a public-private
consortium has developed a structured template for planning and reporting on the …

Head shop: Generating animated head models with anatomical structure

K Kähler, J Haber, H Yamauchi, HP Seidel - Proceedings of the 2002 …, 2002 - dl.acm.org
We present a versatile construction and deformation method for head models with anatomical
structure, suitable for real-time physics-based facial animation. The model is equipped …

[HTML][HTML] Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered …

…, E Livingstone, I Satzger, KC Kähler - European Journal of …, 2017 - Elsevier
Aim Programmed cell death protein 1 (PD-1) inhibitors are a common treatment strategy for
metastatic melanoma and other tumour entities. Clinical trials usually exclude patients with …

Reanimating the dead: reconstruction of expressive faces from skull data

K Kähler, J Haber, HP Seidel - ACM Transactions on Graphics (TOG), 2003 - dl.acm.org
… We build our system on the deformable, anatomy-based head model described by Kahler
et al. [2002]. There, a generic face mesh with underlying muscle and bone layers is deformed …